BioCentury
ARTICLE | Company News

D-Pharm, Jiangsu NHWA deal

May 7, 2012 7:00 AM UTC

D-Pharm received a $1 million milestone payment from Jiangsu NHWA under a 2011 deal that granted Jiangsu NHWA exclusive rights to develop and commercialize DP-VPA in China for epilepsy. The milestone...